• 2005

Company Description

Paloma Pharmaceuticals, Inc. is an early stage drug development company focusing on pathologies showing an aberrant up-regulation of the

Paloma Pharmaceuticals, Inc. is an early stage drug development company focusing on pathologies showing an aberrant up-regulation of the PI3K/Akt/mTOR pathway including cancer, ocular diseases (macular degeneration and diabetic retinopathy), arthritis, fibrotic diseases (renal and pulmonary fibrosis), CNS (epilepsy and neurodegenerative diseases), antiviral (HIV/AIDS) and skin diseases (psoriasis, atopic dermatitis and photodamage/wrinkling).